T2 Biosystems (NASDAQ:TTOO) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report released on Friday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Stock Performance

TTOO stock opened at $0.06 on Friday. T2 Biosystems has a 12-month low of $0.06 and a 12-month high of $6.95. The company’s fifty day simple moving average is $0.31 and its 200 day simple moving average is $1.41.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.